• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Infection and immunity >Vaccination with the Recombinant Major Outer Membrane Protein Elicits Antibodies to the Constant Domains and Induces Cross-Serovar Protection against Intranasal Challenge with Chlamydia trachomatis
【24h】

Vaccination with the Recombinant Major Outer Membrane Protein Elicits Antibodies to the Constant Domains and Induces Cross-Serovar Protection against Intranasal Challenge with Chlamydia trachomatis

机译：重组主要外膜蛋白的疫苗接种使抗体具有恒定结构域，并诱导针对沙眼衣原体的鼻内攻击的跨血清保护。

获取原文
       
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

To determine the ability of the major outer membrane protein (MOMP) to elicit cross-serovar protection, groups of mice were immunized by the intramuscular (i.m.) and subcutaneous (s.c.) routes with recombinant MOMP (rMOMP) from Chlamydia trachomatis serovars D (UW-3/Cx), E (Bour), or F (IC-Cal-3) or Chlamydia muridarum strain Nigg II using CpG-1826 and Montanide ISA 720 VG as adjuvants. Negative-control groups were immunized i.m. and s.c. with Neisseria gonorrhoeae recombinant porin B (Ng-rPorB) or i.n. with Eagle's minimal essential medium (MEM-0). Following vaccination, the mice developed antibodies not only against the homologous serovar but also against heterologous serovars. The rMOMP-vaccinated animals also mounted cell-mediated immune responses as assessed by a lymphoproliferative assay. Four weeks after the last immunization, mice were challenged i.n. with 104 inclusion-forming units (IFU) of C. muridarum. The mice were weighed for 10 days and euthanized, and the number of IFU in their lungs was determined. At 10 days postinfection (p.i.), mice immunized with the rMOMP of C. muridarum or C. trachomatis D, E, or F had lost 4%, 6%, 8%, and 8% of their initial body weight, respectively, significantly different from the negative-control groups (Ng-rPorB, 13%; MEM-0, 19%; P 6. The median number of IFU recovered from mice immunized with rMOMP from serovars D, E, and F were 0.38 × 106, 7.56 × 106, and 11.94 × 106 IFU, respectively. All the rMOMP-immunized animals had significantly less IFU than the Ng-rPorB (40 × 106)- or MEM-0 (70 × 106)-immunized mice (P < 0.05). In conclusion, vaccination with rMOMP can elicit protection against homologous and heterologous Chlamydia serovars.
机译：为了确定主要的外膜蛋白（MOMP）引起交叉血清保护的能力，通过沙眼衣原体沙眼衣原体D（UW）的重组MOMP（rMOMP），通过肌内（im）和皮下（sc）途径免疫各组小鼠-3 / Cx），E（布尔）或F（IC-Cal-3）或鼠衣原体Nigg II菌株，使用CpG-1826和Montanide ISA 720 VG作为佐剂。阴性对照组在当天早上免疫。和s.c.用淋病奈瑟氏球菌重组孔蛋白B（Ng-rPorB）或i.n.使用Eagle的基本必需培养基（MEM-0）。接种疫苗后，小鼠不仅产生针对同源血清型的抗体，而且还针对异源血清型产生抗体。如通过淋巴增生测定所评估，rMOMP疫苗接种的动物还具有细胞介导的免疫反应。在最后一次免疫后四周，对小鼠进行i.n攻击。与104个muridarum包涵体形成单位（IFU）。将小鼠称重10天并实施安乐死，并确定其肺中IFU的数量。在感染后第10天（pi），用鼠莫德氏梭菌或沙眼衣原体D，E或F的rMOMP免疫的小鼠的体重减轻了4％，6％，8％和8％分别与阴性对照组（Ng-rPorB，13％; MEM-0，19％; P 6）显着不同。从用rMOMP免疫的小鼠血清D，E和F中回收的IFU中位数分别为0.38×106、7.56×106和11.94×106 IFU，所有rMOMP免疫的动物的IFU均显着低于Ng-rPorB（40×106）-或MEM-0（70×106）免疫的小鼠（P <0.05）。总之，rMOMP疫苗接种可引起针对同源和异源衣原体血清型的保护。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号